# DEXCOM, INC. (DXCM) · Edgar & Edgarette company card

> Dexcom (DXCM) grew revenue 15.6% in FY2025 to $4.7 billion, operating margin 19.6% against a 1.2% median for surgical & medical instruments & apparatus, equity 43.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1093557 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/DXCM) · [JSON](https://www.pops4.com/boards/company/DXCM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $4.7B |
| Revenue growth, 1 year | 15.6% |
| Revenue growth per year | 17.5% |
| Operating margin | 19.6% (prior year 14.9%) |
| Net margin | 17.9% |
| Operating cash flow | $1.4B |
| Capital spending | $364M |
| Free cash flow | $1.1B |
| Cash | $918M |
| Long-term debt | — |
| Total assets | $6.3B |
| Total equity | $2.7B |
| Equity ÷ assets | 43.3% |
| Return on equity | 30.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.98 (safe zone)
- Piotroski F: 8 of 9 (strong)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $4.7B (FY2025). Experience: revenue up 15.6% on the year, up 17.5% a year over 4 years; operating margin 19.6%, up from 14.9%. Soundness: equity 43.3% of assets, return on equity 30.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $4.8B and $5.8B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $4.5B to $6.3B. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin 19.6% against a 1.2% median; growth 15.6% against 11.6%.

Range logged 2026-09-25, receipt 3bbb53c6cb3a7ac4, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-09-14 ([filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000175/0001093557-26-000175-index.htm))

## Recent filings

- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000195/0001093557-26-000195-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000193/0001093557-26-000193-index.htm)
- 8-K · filed 2026-09-14 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000175/0001093557-26-000175-index.htm)
- 8-K · filed 2026-09-10 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000167/0001093557-26-000167-index.htm)
- 10-Q · filed 2026-07-30 · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000143/0001093557-26-000143-index.htm)
- 8-K · filed 2026-07-30 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000142/0001093557-26-000142-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001093557.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1093557

## Cite

POPS4, Edgar & Edgarette: DEXCOM, INC. (DXCM) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/DXCM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.